Avantax Planning Partners Inc. decreased its position in shares of Chemed Co. (NYSE:CHE – Free Report) by 10.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 511 shares of the company’s stock after selling 57 shares during the period. Avantax Planning Partners Inc.’s holdings in Chemed were worth $271,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors have also made changes to their positions in CHE. CIBC Asset Management Inc boosted its position in Chemed by 5.1% in the fourth quarter. CIBC Asset Management Inc now owns 457 shares of the company’s stock valued at $242,000 after buying an additional 22 shares in the last quarter. EP Wealth Advisors LLC boosted its position in Chemed by 1.9% in the third quarter. EP Wealth Advisors LLC now owns 1,354 shares of the company’s stock valued at $814,000 after buying an additional 25 shares in the last quarter. Independent Advisor Alliance boosted its position in Chemed by 1.1% in the fourth quarter. Independent Advisor Alliance now owns 2,279 shares of the company’s stock valued at $1,207,000 after buying an additional 25 shares in the last quarter. First Heartland Consultants Inc. boosted its position in Chemed by 7.2% in the third quarter. First Heartland Consultants Inc. now owns 508 shares of the company’s stock valued at $305,000 after buying an additional 34 shares in the last quarter. Finally, Argonautica Private Wealth Management Inc. boosted its position in Chemed by 7.2% in the fourth quarter. Argonautica Private Wealth Management Inc. now owns 505 shares of the company’s stock valued at $268,000 after buying an additional 34 shares in the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.
Insider Transactions at Chemed
In other Chemed news, VP Brian C. Judkins purchased 145 shares of the business’s stock in a transaction dated Monday, December 30th. The shares were bought at an average price of $519.50 per share, for a total transaction of $75,327.50. Following the completion of the acquisition, the vice president now owns 1,678 shares in the company, valued at approximately $871,721. This trade represents a 9.46 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $593.67, for a total transaction of $1,187,340.00. Following the transaction, the chief executive officer now directly owns 102,679 shares of the company’s stock, valued at $60,957,441.93. This represents a 1.91 % decrease in their position. The disclosure for this sale can be found here. 3.32% of the stock is owned by company insiders.
Wall Street Analyst Weigh In
Check Out Our Latest Stock Analysis on CHE
Chemed Stock Performance
Shares of NYSE:CHE opened at $588.73 on Thursday. The firm has a market cap of $8.62 billion, a PE ratio of 29.75, a price-to-earnings-growth ratio of 2.15 and a beta of 0.43. The firm’s fifty day moving average is $556.60 and its 200-day moving average is $564.27. Chemed Co. has a 52 week low of $512.12 and a 52 week high of $654.62.
Chemed Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, March 14th. Stockholders of record on Monday, February 24th will be issued a dividend of $0.50 per share. The ex-dividend date is Monday, February 24th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.34%. Chemed’s dividend payout ratio (DPR) is presently 10.05%.
Chemed Company Profile
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Recommended Stories
- Five stocks we like better than Chemed
- The Most Important Warren Buffett Stock for Investors: His Own
- Ramaco Resources Pins Hopes on Coal’s Untapped Potential
- Stock Analyst Ratings and Canadian Analyst Ratings
- NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
- Stock Sentiment Analysis: How it Works
- Why Energy Transfer Belongs on Your Watchlist
Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHE – Free Report).
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.